Identifying ways to increase the proportion of patients with melanoma who have clinically meaningful and durable responses to immune...
Former Vice President Joe Biden returned to the stage at the American Association for Cancer Research (AACR) Annual Meeting...
Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with...
Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the...
April symbolizes a progressive time for cancer researchers around the world. From April 1-5, over 20,000 cancer scientists will...
A big career fair can be somewhat intimidating, so we asked some hiring experts for their advice on how...
In addition to the robust scientific program at this year’s AACR Annual Meeting in Washington, D.C., a number of...
As social media continues to rapidly grow as a leading source of news and information, it has evolved to...
The AACR Annual Meeting, to be held in Washington, D.C., April 1-5, will showcase the best cancer science and...
Guest Post by Cynthia Ryan, PhD Past Mentor in the AACR’s Scientist↔Survivor Program (SSP)